Industries > Pharma > Global Contraceptive Devices Market Forecast to 2027

Global Contraceptive Devices Market Forecast to 2027

Male Condoms, Female Condoms, Diaphragms, Sponges, Vaginal Rings, Subdermal/Contraceptive Implants, Intra-uterine Devices (IUDs), Copper IUD, Hormonal IUD

PUBLISHED: 20 December 2017
PAGES: 186
PRODUCT CODE: PHA0271

Clear
WOOCS 2.2.1

The global contraceptive devices market is expected to grow at a CAGR of 7.5% in the first half of the forecast period. In 2016, the market was estimated at $12.1bn and dominated by the condoms submarket followed by the IUD submarket.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 186-page report you will receive 67 tables and 84 figures– all unavailable elsewhere.

The 186-page report provides clear detailed insight into the global contraceptive devices market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

• Global Contraceptive Devices Market Forecast to 2027

• This report also breaks down the revenue forecast for the global contraceptive devices market by type:
– Condoms:
Male and Female
– Diaphragms
– Sponges
– Vaginal Rigs
– Subdermal/Contraceptive Implants
– IUDs:
Copper IUD and Hormonal IUD

• This report provides individual revenue forecasts to 2027 for these regional and national markets:
– North America:
US & Canada
– Europe: the UK, Germany, France, Italy, Rest of Europe
– Asia-Pacific: China, Japan, India, Rest of Asia-Pacific
Rest of the World (RoW): Latin America, Middle East & Africa

Global Contraceptive Devices Market Forecast to 2027

• This report discusses the SWOT Analysis and PEST Analysis of the global contraceptive devices market.

• Our study discusses the selected leading companies that are the major players in the global contraceptive devices market:
– Bayer AG
– Reckitt Benckiser Group plc
– Merck Sharp & Dohme Corp.
– Church & Dwight Co., Inc.
– Teva Pharmaceutical Industries, Ltd.
– Allergan plc
– Ansell Limited (Now Humanwell)
– The Female Health Company (a division of VERU Inc.)
– Karex Industries
– Mayer Laboratories
– Kessel Medintim GmbH
– Okamato Industries, Inc.
– Agile Therapeutics, Inc.
– Eurogine S.L.

Visiongain’s study is intended for anyone requiring commercial analyses for the global contraceptive devices market. You find data, trends and predictions.

Buy our report today Global Contraceptive Devices Market Forecast to 2027: Male Condoms, Female Condoms, Diaphragms, Sponges, Vaginal Rings, Subdermal/Contraceptive Implants, Intra-uterine Devices (IUDs), Copper IUD, Hormonal IUD.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Contraceptive Devices Market Forecast to 2027


Download sample pages

Complete the form below to download your free sample pages for Global Contraceptive Devices Market Forecast to 2027


Latest Pharma news

Visiongain Publishes Top 50 Biosimilar Drug Manufacturers 2021

Growing demand for cost-effective drugs; rising prevalence of chronic diseases; mounting investment in drug R&D by biopharmaceutical companies; new product launches and rising acceptance of biosimilars in North America region are some of the major factors that propel the biosimilars market growth.

25 November 2020

READ

Visiongain Publishes Advanced Therapy Medicinal Products (ATMP) Market Report 2021-2031

Currently, the ATMP market is at a nascent stage and is expected to flourish during near future owing to increasing research and development activities and rising use of ATMP therapy products in treatment areas with low or no alternative treatment options support the market growth

24 November 2020

READ

Visiongain Publishes Biological Imaging Reagents Market Report 2021-2031

Increasing prevalence of cardiovascular diseases is increasing demand of biological imaging reagents for the diagnosis and treatment of cardiovascular diseases due to this reason increasing prevalence of cardiovascular diseases is acting as a driver for biological imaging reagent market.

13 November 2020

READ

Visiongain Publishes Antihypertensive Drugs Market Report 2021-2031

Hypertensive is the most common disease around the world. However, number of people suffering from hypertensive has increased very significantly from last few years. Hypertensive can occur due to consumption of tobacco, too much salt (sodium) and little potassium in your diet, alcohol and to people being overweight or obese.

13 November 2020

READ

Categories

Category